Colloidal systems for tumor targeting

Hybridoma

Volumn 16, Issue 1, 1997, Pages 119-125

  Storm, G ^a   Crommelin, D J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BETA GLUCURONIDASE; CISPLATIN; CYTOSTATIC AGENT; DAUNORUBICIN; DIPHTHERIA TOXIN; DOXORUBICIN; DRUG CARRIER; EPIRUBICIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLIPOSOME; IMMUNOSTIMULATING AGENT; LIPOSOME; MONOCLONAL ANTIBODY; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; PRODRUG;

CANCER CHEMOTHERAPY; COLLOID; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; METASTASIS; NONHUMAN; OVARY CARCINOMA; PARTICLE SIZE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030964439     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1997.16.119     Document Type: Conference Paper

References (19)

1. Crommelin DJA, and Storm G: Drug Targeting. In: Comprehensive Medicinal Chemistry. Mansch C, Sammes PG and Taylor JD (Eds.). Pergamon Press, Oxford, 1990, pp. 661-701.
2. Krinick ML, and Kopecek J: Soluble Polymers as Targetable Drug Carriers. In: Handbook of Experimental Pharmacology. Juliano RL (Ed.). Springer Verlag, Berlin, 1991, pp. 105-179.
3. Meijer DKF, Jansen RW, and Molema G: Drug targeting systems for antiviral agents: options and limitations. Antiviral Res 1992;18:215-258.
4. Poznansky MJ, and Juliano RL: Biological approaches to the controlled delivery of drugs: A critical review. Pharmacol Rev 1984;36:277-336.
5. Nässander UK, Storm G, Peelers PAM, and Crommelin DJA: Liposomes. In: Biodegradable Polymers as Drug Delivery Systems. Chasin M, and Langer R (Eds.), Marcel Dekker, New York, 1990, pp. 261-333.
6. Storm G, Wilms HP, and Crommelin DJA: Liposomes and biotherapeutics. Biotherapy 1991;3:25-42.
7. Storm G, Oussoren C, Peelers PAM, and Barenholz Y: Tolerabilily of liposomes in vivo. In: Liposome Technology. Gregoriadis G (Ed.). CRC Press Inc, Boca Ralon, FL, 1993, pp. 345-383.
8. Gregoriadis G (Ed.). Liposome Technology. CRC Press Inc., Boca Raton, FL, 1993.
9. Poste G: Drug targeting in cancer therapy. In: Receptor-mediated targeting of Drugs. Gregoriadis G, et al. (Eds.). Plenum Press, New York, 1985, pp. 427-474.
10. Spanjer HH, and Scherphof G: Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo. Biochim Biophys Acta 1983;734:40-47.
11. Jain RK: Transport of molecules in the tumor interstitium: A review. Cancer Res 1987;47:3039-3051.
12. Daemen T, Hoedemakers R, Storm G, and Scherphof GL: Opportunities in targeled drug delivery to Kupffer cells: delivery of immunomodulators to Kupffer cells-activation of tumoricidal properties. Adv Drug Del Rev 1995;17:21-30.
13. Storm G, Nässander UK, Roerdink FH, Steerenberg PA, De Jong WH, and Crommelin DJA: Studies on the mode of action of doxorubicin liposomes. In: Liposomes in the Therapy of Infectious Diseases and Cancer. Lopez-Berestein G and Fidler IJ (Eds.). Alan R Liss, Inc, New York, 1989, pp. 105-116.
14. Allen TM, Hansen CB, and Guo LSS: Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta 1993; 1150:9-16.
15. Senior JH: Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Crit Rev Ther Drug Carrier Syst 1987;3: 123-193.
16. Mangat S and Patel HM: Lymph node localization of non-specific antibody coated liposomes. Life Sci 1985;36:1917-1925.
17. Patel HH: Fate of liposomes in the lymphatics. In: Liposomes as Drug Carriers. Gregoriadis G (Ed.). J Wiley & Sons, Ltd, Chichester, 1988, pp. 51-62.
18. Feldman GB, and Knapp RC: Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am J Obstet Gynecol 1974;119:991-994.
19. Vingerhoeds MH, Storm G, and Crommelin DJA: Immunoliposomes in vivo. Immunomethods 1994;4:259-272.